Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...
DexCom (NASDAQ:DXCM – Get Free Report) had its price target increased by equities researchers at Citigroup from $101.00 to ...
PNC Financial Services Group Inc. raised its position in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 21.5% in the fourth ...
Citi raised the firm’s price target on DexCom (DXCM) to $104 from $101 and keeps a Buy rating on the shares. The firm adjusted medical ...
BofA keeps a Buy rating on DexCom (DXCM) with a $105 price target after Dexcom announced it received a warning letter from the FDA.
DexCom's growth is slowing with 2024 marking the slowest growth year in a decade and 2025 expected to follow suit with ~14% ...
it appears that whales have been targeting a price range from $65.0 to $95.0 for DexCom over the last 3 months. Analyzing Volume & Open Interest In today's trading context, the average open ...
Paycom Software (PAYC) shares advanced as KeyBanc upgraded the stock and raised the price target on optimism about sales, ...
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $60.0 to $120.0 for DexCom over the last 3 months. Looking at the ...
it appears that whales have been targeting a price range from $60.0 to $120.0 for DexCom over the last 3 months. Insights into Volume & Open Interest Looking at the volume and open interest is a ...
In light of these developments, Bernstein analysts raised their price target for DexCom to $100, up from $89, while maintaining an Outperform rating. This adjustment follows DexCom’s return to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results